| | |
Per Share
|
| |
Total
|
| | | | ||||||
公開發行價格
|
| | | $ | 9.97 | | | | | $ | 219,340,000 | | | | ||
承銷折扣及佣金(1)
|
| | | $ | 0.5982 | | | | | $ | 13,160,400 | | | | ||
向Iovance生物治療公司提供費用前
|
| | | $ | 9.3718 | | | | | $ | 206,179,600 | | | |
目錄
|
| | | | | |
| | |
頁
|
|||
招股章程 | | | ||||
關於本招股説明書補編
|
| | | | S-ii | |
關於前瞻性語句的説明
|
| | | | S-iii | |
Summary | | | | | S-1 | |
Risk Factors
|
| | | | S-6 | |
Use of Proceeds
|
| | | | S-9 | |
美國聯邦所得税對非美國持有者的影響
|
| | | | S-10 | |
Underwriting
|
| | | | S-14 | |
Legal Matters
|
| | | | S-21 | |
Experts
|
| | | | S-21 | |
在其中可以找到更多信息
|
| | | | S-21 | |
引用某些信息,
|
| | | | S-22 | |
| | | | | Page | |
招股説明書 | | | | | | |
About This Prospectus
|
| | | | 1 | |
Iovance生物治療學公司
|
| | | | 2 | |
Risk Factors
|
| | | | 4 | |
關於前瞻性語句的説明
|
| | | | 5 | |
收益與固定費用的比率和優惠股息
|
| | | | 6 | |
Use of Proceeds
|
| | | | 7 | |
我們可能提供的證券
|
| | | | 8 | |
Description of Securities
|
| | | | 9 | |
普通股
的描述
|
| | | | 9 | |
優先股
的描述
|
| | | | 11 | |
債務證券的描述
|
| | | | 14 | |
Description Of Warrants
|
| | | | 22 | |
Description of Units
|
| | | | 23 | |
Description of Rights
|
| | | | 24 | |
Plan of Distribution
|
| | | | 26 | |
Legal Matters
|
| | | | 28 | |
Experts
|
| | | | 28 | |
在其中可以找到更多信息
|
| | | | 28 | |
引用某些信息,
|
| | | | 29 |
Underwriter
|
| |
Number of
股份 |
| |||
Jefferies有限公司
|
| | | | 22,000,000 | | |
共計
|
| | | | 22,000,000 | | |
|
| | |
每股
|
| |
共計
|
| ||||||||||||||||||
| | |
無
選擇 購買 額外 股份 |
| |
帶着
選擇 購買 額外 股份 |
| |
無
選擇 購買 額外 股份 |
| |
帶着
選擇 購買 額外 股份 |
| ||||||||||||
公開發行價格
|
| | | $ | 9.97 | | | | | $ | 9.97 | | | | | $ | 219,340,000 | | | | | $ | 252,241,000 | | |
我們支付的包銷折扣和佣金
|
| | | $ | 0.5982 | | | | | $ | 0.5982 | | | | | $ | 13,160,400 | | | | | $ | 15,134,460 | | |
在支出前付給我們的款項
|
| | | $ | 9.3718 | | | | | $ | 9.3718 | | | | | $ | 206,179,600 | | | | | $ | 237,106,540 | | |
| | |
頁
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
生物治療學公司
|
| | | | 2 | | |
RISK FACTORS
|
| | | | 4 | | |
關於前瞻性語句的警告説明
|
| | | | 5 | | |
收益與固定費用的比率和優惠股息
|
| | | | 6 | | |
USE OF PROCEEDS
|
| | | | 7 | | |
我們可以提供的證券
|
| | | | 8 | | |
DESCRIPTION OF SECURITIES
|
| | | | 9 | | |
普通股
的描述
|
| | | | 9 | | |
優先股
的描述
|
| | | | 11 | | |
債務證券的描述
|
| | | | 14 | | |
DESCRIPTION OF WARRANTS
|
| | | | 22 | | |
DESCRIPTION OF UNITS
|
| | | | 23 | | |
DESCRIPTION OF RIGHTS
|
| | | | 24 | | |
PLAN OF DISTRIBUTION
|
| | | | 26 | | |
LEGAL MATTERS
|
| | | | 28 | | |
EXPERTS
|
| | | | 28 | | |
在其中可以找到更多信息
|
| | | | 28 | | |
引用某些信息的合併
|
| | | | 29 | | |
| | |
截至12月31日的年度,
|
| |
六個月
終結 六月三十日, 2018 |
| ||||||||||||||||||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |
2014
|
| |
2013
|
| |||||||||||||||||||||
收入與固定費用的比率(1)
|
| | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |